Delivery Order SPE2DB20D3103-SPE2DB25FP2Y5
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,114.80, is for the delivery of Kanjinti 420 mg vials and has a completion date of February 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KANJINTI 420 MG VIALS, with a firm fixed price ceiling value of $5,363.42 and a period of performance through June 16, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of KANJINTI 420 MG VIALS. The firm-fixed-price contract has a ceiling value of $14,564.76 and a completion date of May 10, 2024. AmerisourceBergen, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $31,672.20 fixed-price contract is for the supply of 420 mg vials of the oncology medication Kanjinti. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on June 5, 2025. The contract has a ceiling value of $35,623.68 and a completion date of June 6, 2025. It is a Firm Fixed Price contract to provide a variety of pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $28,080.24, is for the delivery of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $101,524.70 firm fixed-price contract is for the delivery of a variety of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,700.10 firm fixed-price contract was awarded on June 9, 2025 by the Defense Logistics Agency (DLA), with an ultimate completion date of June 10, 2025. The contract provides for the delivery of a variety of pharmaceutical and medical products, including prescription medications, medical devices, and other healthcare-related supplies, to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,597.28 firm-fixed-price contract is for the delivery of pharmaceutical products and medical supplies to support military and federal healthcare programs. The contract has a performance period through May 2025 and is not set aside for any special business category. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,965.49 contract is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management, as well as specialized medical supplies. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a...